Alimba, Darwin O.

HRN: 22-81-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFTRIAXONE 1G (VIAL)
04/01/2023
04/08/2023
IV
2gm
OD
Non-healing Wound
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: